These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 8641481

  • 1. Effect of preovulatory insertion of Norplant implants over luteinizing hormone secretion and follicular development.
    Brache V, Alvarez F, Faundes A, Cochon L, Thevenin F.
    Fertil Steril; 1996 Jun; 65(6):1110-4. PubMed ID: 8641481
    [Abstract] [Full Text] [Related]

  • 2. Ultrasonographic and endocrine evaluation of ovarian function among Norplant implants users with regular menses.
    Alvarez F, Brache V, Faundes A, Tejada AS, Thevenin F.
    Contraception; 1996 Nov; 54(5):275-9. PubMed ID: 8934060
    [Abstract] [Full Text] [Related]

  • 3. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
    Faundes A, Brache V, Tejada AS, Cochon L, Alvarez-Sanchez F.
    Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
    [Abstract] [Full Text] [Related]

  • 4. Timing of onset of contraceptive effectiveness in Norplant implant users. Part I. Changes in cervical mucus.
    Dunson TR, Blumenthal PD, Alvarez F, Brache V, Cochon L, Dalberth B, Glover L, Remsburg R, Vu K, Katz D.
    Fertil Steril; 1998 Feb; 69(2):258-66. PubMed ID: 9496339
    [Abstract] [Full Text] [Related]

  • 5. Sonographic assessment of ovarian and endometrial changes during long-term Norplant use and their correlation with hormonal levels.
    Shaaban MM, Segal S, Salem HT, Ghaneimah SA, Khalifa EA, Ahmed AG.
    Fertil Steril; 1993 May; 59(5):998-1002. PubMed ID: 8486202
    [Abstract] [Full Text] [Related]

  • 6. Temporal relationship between Uniplant insertion and changes in cervical mucus.
    Barbosa IC, Coutinho E, Hirsch C, Ladipo OA, Olsson SE, Ulmsten U.
    Contraception; 1996 Oct; 54(4):213-7. PubMed ID: 8922874
    [Abstract] [Full Text] [Related]

  • 7. First week drug concentrations in women with levonorgestrel rod or Norplant capsule implants.
    Sivin I, Lähteenmäki P, Mishell DR, Alvarez F, Diaz S, Ranta S, Grozinger C, Lacarra M, Brache V, Pavez M, Nash H, Stern J.
    Contraception; 1997 Nov; 56(5):317-21. PubMed ID: 9437561
    [Abstract] [Full Text] [Related]

  • 8. Timing of onset of contraceptive effectiveness in Norplant implant users. II. Effect on the ovarian function in the first cycle of use.
    Brache V, Blumenthal PD, Alvarez F, Dunson TR, Cochon L, Faundes A.
    Contraception; 1999 Apr; 59(4):245-51. PubMed ID: 10457869
    [Abstract] [Full Text] [Related]

  • 9. Sex hormone binding globulin and free levonorgestrel index in the first week after insertion of Norplant implants.
    Alvarez F, Brache V, Tejada AS, Cochon L, Faundes A.
    Contraception; 1998 Oct; 58(4):211-4. PubMed ID: 9866001
    [Abstract] [Full Text] [Related]

  • 10. Norplant implants: the mechanism of contraceptive action.
    Segal SJ, Alvarez-Sanchez F, Brache V, Faundes A, Vilja P, Tuohimaa P.
    Fertil Steril; 1991 Aug; 56(2):273-7. PubMed ID: 1906407
    [Abstract] [Full Text] [Related]

  • 11. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.
    Xiao B, Zeng T, Wu S, Sun H, Xiao N.
    Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of enlarged ovarian follicles among users of levonorgestrel subdermal contraceptive implants (Norplant).
    Alvarez-Sanchez F, Brache V, de Oca VM, Cochon L, Faúndes A.
    Am J Obstet Gynecol; 2000 Mar; 182(3):535-9. PubMed ID: 10739504
    [Abstract] [Full Text] [Related]

  • 13. Immediate postpartum insertion of the norplant contraceptive device.
    Molland JR, Morehead DB, Baldwin DM, Castracane VD, Lasley B, Bergquist CA.
    Fertil Steril; 1996 Jul; 66(1):43-8. PubMed ID: 8752609
    [Abstract] [Full Text] [Related]

  • 14. Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception.
    Kekkonen R, Lähteenmäki P, Luukkainen T, Tuominen J.
    Fertil Steril; 1993 Oct; 60(4):610-5. PubMed ID: 8405512
    [Abstract] [Full Text] [Related]

  • 15. Abnormal endocrine profile among women with confirmed or presumed ovulation during long-term Norplant use.
    Alvarez F, Brache V, Tejada AS, Faúndes A.
    Contraception; 1986 Feb; 33(2):111-9. PubMed ID: 3084166
    [Abstract] [Full Text] [Related]

  • 16. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R, Alfthan H, Haukkamaa M, Heikinheimo O, Luukkainen T, Lähteenmäki P.
    Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
    [Abstract] [Full Text] [Related]

  • 17. Effect of daily low dose mifepristone on the ovarian cycle and on dynamics of follicle growth.
    Cameron ST, Thong KJ, Baird DT.
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):407-14. PubMed ID: 7586613
    [Abstract] [Full Text] [Related]

  • 18. Serum concentrations of estradiol, progesterone, and levonorgestrel are not determinants of endometrial histology or abnormal bleeding in long-term Norplant implant users.
    Darney PD, Taylor RN, Klaisle C, Bottles K, Zaloudek C.
    Contraception; 1996 Feb; 53(2):97-100. PubMed ID: 8838486
    [Abstract] [Full Text] [Related]

  • 19. Effects of a sequential regimen of mifepristone-medroxyprogesterone acetate on ovarian function, endometrial development and hormonal parameters.
    Croxatto HB, Massai MR, Salvatierra AM, Fuentealba B, Croxatto HD, Lähteenmäki P.
    Contraception; 1996 Aug; 54(2):79-86. PubMed ID: 8842583
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
    Lemay A, Faure N, Labrie F, Fazekas AT.
    Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.